SEC Form 4 · accession 0001209191-16-114895
LEMAITRE VASCULAR INC · LMAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David B Roberts
Officer — President and Director · Director
Period of report
Apr 15, 2016
Accepted (ET)
Apr 19, 2016 · 5:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001158895
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 15, 2016 | M | 39,531 | $3.00 | A | 147,136 | D | |
| Common StockF2,F3 | Apr 18, 2016 | S | 1,766 | $16.1006 | D | 145,370 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $3.00 | Apr 15, 2016 | M | 39,531 | D | Jul 27, 2009 | Jul 27, 2016 | Common Stock | 39,531 | 0 | D |
Explanation of responses
- F1Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
- F2This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- F3The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $16.10 to $16.11. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
- F4This option is fully vested and exercisable.